Oxford Biomedica has rebranded as OXB, unveiling a new visual identity that aligns with its evolution into a global pure-play cell and gene therapy CDMO. The updated branding highlights OXB’s focus on technical excellence, innovation, and consistent high-quality delivery across
Oxford Biomedica Contract Manufacturing & Development (CDMO) Profile Oxford Biomedica is an innovative leading viral vector specialist focused on delivering life changing therapies to patients. They offer end to end capabilities, from plasmid design and optimization, to clinical and commercial
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
